Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed; no study data or page content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding/operating-status banner has been removed; core trial information remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check43 days agoChange DetectedThe history shows updates to Study Status, Recruitment Status, and Contacts/Locations across multiple versions. These updates reflect changes in the trial's current state and logistical details over time.SummaryDifference0.1%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check93 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; removed 'Back to Top' link. No evident changes to core content.SummaryDifference0.8%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.